chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe body/muscle ache, chills, and headache for approximately 24 hours after injection. Redness and swelling around injection site lasted longer.
PT (DOB  12/14/1958) received the COVID vaccine (Pfizer dose 1, Lot# EW0150, exp 7/31/2021) at 1525. The client reported feeling dizzy and lightheaded, and his caregiver reported that he was "red and sweaty". EMT alerted the RNs and responded to the client. Upon observation, the EMT observed that the client appeared flushed and diaphoretic. The client was accompanied by his caregiver who reported that the client has a medical history of hypertension, orthostatic hypotension, intellectual disability, schizophrenia, diabetes mellitus 2, and bell's palsy. The client has no allergies and takes the following medications: metformin, lipitor. clozapam, metoprolol, cogentin, iron, prostigmine, and farxiga. At 1530, the EMT obtained a blood pressure of 180/118, with a heart rate of 116, respiratory rate of 22, temperature of 99.1 F and pulse oximeter reading of 94%. At 1536, the client's blood pressure was 172/118, with a heart rate of 116, respiratory rate of 20, and pulse oximeter reading of 95%. At this time, the client stated that he was dizzy and feeling anxious. The client reported that he was feeling dizzy before he was vaccinated but that he "forgot" to tell his caregiver. His caregiver reported that the client had not yet eaten or had anything to drink that day. The client was offered and accepted water. The client and his caregiver deferred Benadryl. Repeat vital signs were obtained at 1542: blood pressure of 166/112, heart rate of 116, respiratory rate of 24, temperature of 99.1 F, and a pulse oximeter reading of 95%. The client practiced deep breathing, denied any difficulty breathing, itching or swelling. At 1550, the client reported no longer feeling anxious or dizzy. At this time, the client's color was improved, he no longer was diaphoretic, and he stated "I'm pretty hungry now." Repeat vital signs were as follows: 156/115, heart rate 108, respiratory rate 20, and pulse oximeter reading of 95%. Client left the facility at 1600 after waiting the recommended 30 minutes from initial symptoms, with symptoms resolved at that time. The client ambulated to his car with a steady gait, escorted by the EMT and his caregiver, and his caregiver drove him home.
This case was reported by a consumer via call center representative and described the occurrence of heat rash in a 70-year-old male patient who received SHINGRIX for prophylaxis. On 6th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In May 2018, 14 days after receiving SHINGRIX, the patient experienced heat rash, wrist pain, swelling of wrists and burning sensation. On an unknown date, the outcome of the heat rash, wrist pain, swelling of wrists and burning sensation were recovering/resolving. It was unknown if the reporter considered the heat rash, wrist pain, swelling of wrists and burning sensation to be related to SHINGRIX. Additional details were received as follows: The patient received SHINGRIX in the left deltoid. The patient stated that about 2 weeks after receiving the SHINGRIX vaccine he experienced burning rash sensation on his left hand on the top of his hand between his thumb and 1st finger. It was a prickly heat rash. The patient's left wrist was also swollen and had pain moving his wrist. The patient still had a little wrist pain but the swelling has gone down at the reporting time. The patient provided the contact details of the physician.
Information has been received concerning an 8 year old male with no known allergies who on 19Nov1997 was vaccinated SC in the arm with a first dose of varicella virus vaccine live. There was no illness at the time of vaccination. The reporter indicated that on 03Apr2003 the patient developed a wide spread itchy rash and multiple papular and vesicular lesions. It was reported that the patient's temperature was 97.8. The patient had three contacts with varicella at school. Symptomatic treatment was provided. There were no diagnostic tests or laboratory results. It was noted that the patient recovered. Additional information is not expected.
PATIENT SAID SHE HAD TO LEAVE WORK DAY OF THE VACCINE DUE TO BEING IN PAIN.  TODAY SHE SAYS SHE IS IN EXTREME PAIN. IT DOES NOT MATTER IF SHE IS LYING DOWN, SITTING, OR STANDING.  SHE HAS TO USE A CANE TO WALK (SHE GENERALLY DOES NOT USE A CANE).  SHE IS GOING TO AN URGENT CARE TO BE SEEN
Received vaccine 5:10. 5/11 started with rash headache and excessive fatigue. By 5/15 I?m so tired, feels a bit hard to breathe, migraine, flush, body feels on fire, and itchy. I woke up at 9- and didn?t even realize I fell back asleep until 12. I took my adderal and I?m still falling asleep.
Syncope episode with seizure activity lasting around 5 min. T - 102 degrees. To ER per EMS.
Injection site became red and swollen with an itchy rash more than a week after injection.
Fever, headache, diarrhea, body aches, chills, confusion, cough
Briefly, patient is a 6 month old girl with an ALTE, episode not consistent with a seizure, no postictal period, normal cardiac and vascular exam, episode most likely due to a mucous plug/breath holding spell. Still febrile, may be due to vaccinations, but will evaluate for a UTI. Check a UA and Urine culture. Discharge home after UA results are back, will decide about a course of antibiotics based on the UA results. Follow up with PMD in 1-2 days. Dx: Apparent Life Threatening Event (stopped breathing) admitted for observation.
covid 19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (covid 19) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1) on 08-Apr-2021, PFIZER BIONTECH COVID-19 VACCINE (Dose 2) on 29-Apr-2021 and PFIZER BIONTECH COVID-19 VACCINE (Dose 3) on 04-Nov-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 27-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Dec-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.
I have been fine except for tenderness in the injection site the first 2-3 days and up until 03-11-21 when I began having an itch in the site of the injection which I kept noticing until bedtime.  Then, yesterday, 03-12-21, I noticed that the site was warm to the touch and there is a red rash around the site along with swelling/a tight lump in the site, sensitivity as well as continuation of the itching.   Avoided sleeping on the site due to tenderness.  Upon waking today, 03-13-21, attention was drawn to the site because of the itch and sensitivity; the lump also seems to be a bit bigger.  I did sign up with the v-safe site this morning to follow-up. Not sure of next step....
Didn't receive 2nd dose/more than 35 days since caller got the first dose and does not have the second yet; got really sick/seriously ill; really really weak; no appetite; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (got really sick/seriously ill), ASTHENIA (really really weak), DECREASED APPETITE (no appetite) and PRODUCT DOSE OMISSION ISSUE (Didn't receive 2nd dose/more than 35 days since caller got the first dose and does not have the second yet) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid function abnormal. Concomitant products included LEVOTHYROXINE for Thyroid function abnormal, METFORMIN, LOSARTAN and HYDROCHLOROTHIAZIDE for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced ILLNESS (got really sick/seriously ill), ASTHENIA (really really weak) and DECREASED APPETITE (no appetite). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Didn't receive 2nd dose/more than 35 days since caller got the first dose and does not have the second yet). At the time of the report, ILLNESS (got really sick/seriously ill), ASTHENIA (really really weak) and DECREASED APPETITE (no appetite) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Didn't receive 2nd dose/more than 35 days since caller got the first dose and does not have the second yet) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.1 (abnormal) The temperature fluctuated between 99.4 and 101.8 F, and stayed like that for 4 days.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included vitamins, immune Booster, elderberry, flax seeds.   Most recent FOLLOW-UP information incorporated above includes: On 13-Sep-2021: An event was added.
Patient given extra dose of varicella. MMR with varicella and a varicella dose. Provider did not realize MMR with varicella. No adverse reactions. Medical director, VAERS notified, record entered and family notified.
Sore throat, headache, sneezing, severe upper respiratory that worsened over the next 24-30 hours; patient is 30 weeks pregnant.
This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PRURITUS (Itchiness all over her body). At the time of the report, PRURITUS (Itchiness all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
At clinic event, right after shot given, soreness in right side of throat, almost fainted. Paramedics gave me benedryl to help. That afternoon, eyes completely blurred & almost fainted (with friend) after leaving site -- couldn't see & threw up. Next 2 days, tired and weak. Note, adopted from a country where multiple shots given at birth at same time. University required vaccination for school so got J&J as most natural. Should any additional vaccine be needed, would seem to risk adverse reaction and seems highly risky from a medical perspective. Especially would not want to mix MRNA and non-MRNA shots, per studies from CDC and others.
Body rash noted 11/12/05 per mom . no treatment Rash is rubeola - form rash on trunk and proximal parts of upper and lower extremities
My left arm had been very itchy for 5 days after the vaccine.  Thursday 3/18 around 6pm I felt a pain on the outside my left arm about 5 inches above my elbow, it shortly turned into a group of small pimples,  Friday 3/19 again around 6-7pm I felt a pain on my left shoulder above where I got the vaccine which turned into a group of small.  Saturday 3/20  again around 7pm I felt a rather sharp pain on my inner left arm which turned into small pimples.  Today the upper left side of my body itches, the first group of pimples is now swollen and red, the left shoulder is bumpy and red, and my inner arm is still raw and and looks like pimples.  I also had a 4-5' X 3"hive on the left side of my chest which has since dissipated.
p/vax pt c/o swollen arm w/blisters;pt came into office for assessment;reddened area 4" x 6 7/8" on rt posterior/lateral upper arm;rt arm circumference 3 3/4" larger than 2 small blisters noted around inj site;
Swollen left Armpit and left neck.; Swollen left Armpit and left neck.; This is a spontaneous report from a contactable consumer or other non HCP. A 41-year-old non-pregnant female patient received first dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number: EL9262 and Expiration date was not provided), via an unspecified route of administration, administered in Arm Left on 23Jan2021 13:30 (age at vaccination 41-year-old) as 1ST DOSE, SINGLE for covid-19 immunization. Facility type for vaccination was hospital. The patient's medical history and concomitant medications were not reported. On 25Jan2021 08:00 the patient experienced swollen left armpit and left neck. Treatment was not received by the patient. The outcome of event was not recovered.  Follow-up attempts are completed. No further information is expected.
The pt developed a rash on her hands 2 days post vax that quickly spread to her arms, abdomen and thighs. It is a fine flesh colored slightly pruritic rash.
Heart murmur; Unknown defects; Vaccine exposure before pregnancy; Information has been received from Food and Drugs Administration (FDA) (VAERS number 842575-1) on 22-OCT-2020 referring to a female patient.  The patient's concurrent conditions, medical history and concomitant medications were not reported.  Estimated date of conception (EDC) was 09-JAN-2020, received vaccines on 24-JUN-2019 (HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (lot number R027999, expiration date not reported but upon internal validation stablished as 01-OCT-2020), varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number R030604, expiration date not reported but upon internal validation stablished as 23-OCT-2020), meningococcal B rfHbp rNadA rNHBA OMV vaccine (E. coli) (BEXSERO), diphtheria toxoid, pertussis acellular 3-component vaccine, tetanus toxoid (BOOSTRIX) (lot number reported as 97NL3), hepatitis B virus vaccine rHBsAg (yeast) (ENGERIX-B) (lot number reported as CP275), hepatitis A virus vaccine inactivated (HAVRIX) (lot number reported as PA99T), poliovirus vaccine inactivated (Vero) (IPOL) (lot number reported as P1E701M) and meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) (lot number reported as U6219BA)), also (25-JUL-2019 hepatitis B virus vaccine rHBsAg (yeast) (ENGERIX-B): lot number CP275, diphtheria toxoid (+) tetanus toxoid  (DT VAX) lot# Z116A2) 15-year-old to our clinic at 31 weeks. Received vaccines during known pregnancy. Was given prenatal vitamins on same visit at the vaccines in the clinic. Has not had qaud screen (AFP) done due to (D/T) arrival TO "N.C.". Patient (PT) has been referred D/T heart murmur, unknown defects (cardiac murmur, ill-defined disorder).  The causal relationship between the suspect vaccines and the events was not reported.  Lot number R029177 is an invalid lot number for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). Lot number R029177 does not match any Company product as confirmed by Lot Verification team.  Follow-up information was received via telephone call on 09-NOV-2021: A receptionist confirmed that was not possible to provide additional information regarding this patient's pregnancy; therefore, the pregnancy outcome was updated to Lost to F/U.
Sore arm; lost a bunch when she had sugery; Tremors in her hands/hands started shaking non-stop; Tremors in her hands/hands started shaking non-stop; This is a spontaneous report from a contactable consumer (patient).  A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route of administration on 21Jan2021 at 10:40 at single dose for COVID-19 immunization. The relevant medical history included asthma, tremor (Tremors that runs on her mother's side of the family), neuropathy of hands and arms, high cholesterol, thyroid, neuropathy, vascular gait disorder, cervical stenosis operation from 2018. Concomitant medications included painkiller for neuropathy and unspecified medicines for high cholesterol, thyroid. She stated she received the first dose on 21Jan2021 and experienced tremors in her hands starting the following day. She stated that Friday her hands started shaking non-stop and had done that since then. She also reported having a sore arm. She had occasional tremors that didn't last very long. Since COVID-19 Vaccine had had nonstop shaking of hands since around Friday. Primary care doctor didn't treat her. Went to a pain center and neurologist. No further details provided. Tried to report online, but there were too many questions so she opted out. Does kind of get better if she is real still and lays down, but it still shakes. Never had this before. The patient stated that Friday or Saturday she didn't remember exactly when, sometimes they shake but not very long but this was like nonstop and it's a much more aggressive shaking. She hoped she could get the second one because she wanted the protection. She was not sure of her weight because she lost a bunch when she had surgery but she was about 115. When probed for treatment, she stated that it went away it was a day or so after but the hands were shaking and it's very intense shaking and it's going on and it's not stopping. She didn't have anything for it. It's never been like this before. The outcome of the event tremors in her hands/hands started shaking non-stop was not recovered, while other events were unknown.  Information about lot/batch number has been requested.
Narrative: COVID infection following COVID vaccine series 08/31, Pfizer, dose #1 09/21, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown
Patient's throat 10 minutes after the injection got dry and felt like an object was in it, and his left arm at the shoulder felt like it was numb. Had a little headache.
Severe rash on stomach, back, head, underarms, legs, swollen eye lids, red puffy eye lids and ears, very red inter-ear, pulling at both ears, cranky, fussy, crying non-stop.
Information has been received from the patient's mother referring to a 2.5 year old of female patient. The patient's concurrent condition included sickle beta thalassemia. There was no concomitant medication and drug reactions/allergies. On 27-OCT-2016, the patient was vaccinated with a dose of (wistar ra 27-3) M-M-R II (dose, lot number and expiration date were unknown) subcutaneously. On approximately 03-NOV-2016, 1 week after receiving (wistar ra 27-3) M-M-R II, the patient developed a fever. The patient was taken to an unspecified emergency room and was given unspecified medication to treat fever. Unspecified blood work was performed (results were not reported). The outcome of the event was reported as not recovered. The causal relationship between the event and (wistar ra 27-3) M-M-R II was unknown. Additional information has been requested.
hypotonia, lethargy, central pallor, ashen 2 hrs p/vax;
suspected vaccination failure/came out with the two shot shingles shot, paid for it, shingles in eye; went through a trauma and got shingles in the eye/came out with the two shot shingles shot, paid for it, shingles in eye; scar tissue which makes my vision blurry; terrible trauma; scar; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (experienced shingles when the patient was in his/her 30's). Previously administered products included Shingles vaccine.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, unknown after receiving Shingles vaccine and an unknown time after starting Valtrex, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant), blurred vision, injury and scar. The patient was treated with valaciclovir hydrochloride (Valtrex) and ophthalmologicals (nos) (Eyes Drops (Nos)). On an unknown date, the outcome of the vaccination failure and injury were unknown and the outcome of the ophthalmic herpes zoster was recovered/resolved and the outcome of the blurred vision and scar were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, blurred vision, injury and scar to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 1-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient came out with the two shot shingles shot. The patient's insurance did not cover it, so he/she paid for it. Two months later the patient went through a terrible trauma and got shingles in left eye. The patient was on three different drops for eyes and the Valtrex since 4th February 2022. The patient had scar tissue which made his/her vision blurry, so now the patient had to take the Valtrex for the rest of life. Out of fear the shingles will come back and he/she would lose total vision. The patient stated that you could get shingles many times . So don't sweat the little things and try not to sweat the big things either. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles was not provided
Cough started this am- took the first dose of the Covid vaccine on 12/24, Sore Throat, Headache, Generalized Body Aches.
Feeling lousy; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling bad in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Covid 19 vaccine with an associated reaction of adverse drug reaction.   On 04-MAR-2023, the patient received the 1st dose of Shingrix (left arm). In MAR-2023, an unknown time after receiving Shingrix, the patient experienced feeling bad (Verbatim: Feeling lousy). The outcome of the feeling bad was not recovered/not resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingrix.   It was unknown if the company considered the feeling bad to be related to Shingrix.   Additional Information: GSK Receipt date: 08-MAR-2023 Reporter was a patient that received his dose of Shingrix  He was still feeling lousy today (on the day of reporting).  The patient said the side effects were worse than when he received his Covid-19 vaccine (unknown product).  The Covid-19 vaccine was received prior to receiving the Shingrix vaccine.  The patient disconnected the call before could ask any details about his adverse reactions and consent to follow up with HCP.
Thrombocytopenia - Platelet count on 3/12/21 = 143.  On 7/20/21 PLT =17, 6 and 15 on 7/21/21 and 31 on 7/22/21.  Extensive bruising which was resolving on day 3 of admission.